89bio, Inc.
ETNB
Revenue
0.00
0.000.00%
-Assets
582.14M
▲4.82M▲0.8342%
3 Months ChangeLiabilities
67.22M
▲438.00k▲0.6559%
3 Months ChangeFree Cash Flow
-24.35M
▼-9.36M▼-62.48%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-03
Form 8-K
ID: 0001193125-24-231670
2024-08-07
Form 8-K
ID: 0001193125-24-195999
2024-08-05
Form 10-Q
ID: 0000950170-24-090871
2024-08-05
Form 8-K
ID: 0001193125-24-193906
2024-05-31
Form 8-K
ID: 0001193125-24-151854
2024-05-09
Form 10-Q
ID: 0000950170-24-057180
2024-05-09
Form 8-K
ID: 0001193125-24-135264
2024-04-17
Form 8-K
ID: 0001193125-24-099076
2024-04-10
Form 8-K
ID: 0001193125-24-091945
2024-02-29
Form 8-K
ID: 0001193125-24-053405